-+ 0.00%
-+ 0.00%
-+ 0.00%

Acumen Pharmaceuticals Q1 GAAP EPS $(0.48) Beats $(0.54) Estimate

Benzinga·05/13/2025 11:00:59
Listen to the news
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.54) by 11.11 percent. This is a 92 percent decrease over losses of $(0.25) per share from the same period last year.